Below is a list of the top 25 pharmaceutical companies by market capitalization at the end of December 2018, according to Endpoint News.
The list doesn’t include Johnson & Johnson, which has a market cap of $371 billion, because it is not a “pure play pharma giant” with its many business units, according to the report.
The top 25 pharma players, as of December 2018:
1. Pfizer — $253.2 billion
2. Roche — $212.5 billion
3. Merck & Co. — $198.7 billion
4. Novartis — $195.4 billion
5. AbbVie — $139.6 billion
6. Abbott Laboratories — $127 billion
7. Amgen — $124 billion
8. Eli Lilly — $122.6 billion
9. Novo Nordisk — $112.9 billion
10. Sanofi — $111.3 billion
11. AstraZeneca — $99.2 billion
12. GlaxoSmithKline — $98.2 billion
13. Bristol-Myers Squibb — $84.8 billion
14. Gilead Sciences — $80.9 billion
15. Bayer — $66.6 billion
16. CSL — $62.5 billion
17. Biogen — $60.6 billion
18. Merck KGaA — $46.2 billion
19. Allergan — $45.1 billion
20. Celgene — $44.8 billion
21. Vertex Pharmaceuticals — $42.3 billion
22. Shire — $42 billion
23. Regeneron Pharmaceuticals — $40.4 billion
24. Chugai Pharmaceuticals — $31.5 billion
25. Jiangsu Hengrui Medicine Co. — $29.4 billion
More articles on pharmacy:
10 hospitals seeking pharmacy leaders
Walgreens shaking up C-suite
Generic drugmakers could thrive in a recession, Moody’s says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
